Same Indication

Ondansetron vs Rituximab

Ondansetron vs Rituximab: Overview

This comparison examines the pharmacological differences between Ondansetron and Rituximab.

Mechanism of Action

Ondansetron: Selective 5-HT3 receptor antagonist.

Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

Pharmacokinetics

Half-life: Ondansetron β€” 3-5 hours; Rituximab β€” 22 days.

Chemical Properties

Molecular Formula: Ondansetron β€” C18H19N3O.

Molecular Weight: Ondansetron β€” 293.3660 g/mol.

Type: Ondansetron β€” Small molecule; Rituximab β€” Antibody.